arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Penumbra Inc

PEN
$319.78 ▲ +0.56 (+0.18%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
51 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

Penumbra Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.6B
Dividend Yield —
Revenue Growth 14.9% ↘
Op. Margin 10.5% ↗
ROIC 2.0% →
FCF / Share $0.83 ↘
Trailing P/E 363.4x
Price / Book 8.2x
FCF Yield 0.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 24, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$390.05M
↑ +14.9% —
Net Income Profit after all expenses
$32.58M
↓ -16.9% —
Operating Margin Operating profit as % of sales
10.5%
↑ +3.1% 64th
FCF / Share Free cash flow per share
$0.83
↓ -55.7% —

Health Breakdown

Profitability ↑
67
Returns
75
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 14 years · 51 quarters